Serum autoantibodies as biomarkers for early cancer detection. - Wikidata - thesis-toulmin - TriplyDB

Serum autoantibodies as biomarkers for early cancer detection.

Serum autoantibodies as biomarkers for early cancer detection.

http://www.wikidata.org/entity/Q37622471

about

Potential biomarkers for esophageal cancer Specificity delivers: therapeutic role of tumor antigen-specific antibodies in pancreatic cancer CUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseases Paraneoplastic neurological complications of breast cancer.Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer Early lung cancer diagnosis by biosensors.Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies.Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma Complement factor H autoantibodies are associated with early stage NSCLC.Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma Immunogenicity of autoantigens.Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker.Use of autoantibodies to detect the onset of breast cancer Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.Generation of a cholangiocyte-specific cDNA expression library for the identification of B and T cell autoantigens in murine biliary disease.A multi-analyte serum test for the detection of non-small cell lung cancer.Preliminary study of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential cancer biomarkers.Tumor-associated autoantibody signature for the early detection of gastric cancer.Serological analysis of SEREX-defined medullary breast carcinoma-associated antigens.Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancer Identification of a mimotope for circulating anti-cytokeratin 8/18 antibody and its usage for the diagnosis of breast cancer.Prognostic and diagnostic value of spontaneous tumor-related antibodies Autoantibody against WD repeat domain 1 is a novel serological biomarker for screening of thyroid neoplasia.Exploring the immunoproteome for ovarian cancer biomarker discovery.Serum APE1 autoantibodies: a novel potential tumor marker and predictor of chemotherapeutic efficacy in non-small cell lung cancer Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.Hypoxia integration in the serological proteome analysis unmasks tumor antigens and fosters the identification of anti-phospho-eEF2 antibodies as potential cancer biomarkers.Application of proteomics to cancer early detection Serological proteome analysis of dogs with breast cancer unveils common serum biomarkers with human counterparts.Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens Long noncoding RNA linc-UBC1 is negative prognostic factor and exhibits tumor pro-oncogenic activity in gastric cancer.Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.The network of antigen-antibody reactions in adult women with breast cancer or benign breast pathology or without breast pathology Study of circulating IgG antibodies to peptide antigens derived from BIRC5 and MYC in cervical cancer Proteomics in melanoma biomarker discovery: great potential, many obstacles.

P2860

Q26749416-A6B44210-BEEF-4120-86B2-D104AA026B6A Q26853171-D0A93E17-51ED-4086-A45D-512DAF3BD639 Q26999045-15B7D550-037B-4421-AD29-C5E6F41F6F69 Q28077708-49B14C58-7483-4E11-81F7-124B2535D20A Q28273809-D1EE4F2D-DC23-4D45-92D0-4929D377F95C Q30449799-6ECE659E-F5AB-4BB6-A310-8AC4596BC1CF Q31126986-F4E1DF11-80B4-425E-8440-5C903E533C9D Q33618065-98C299CA-4D08-44F5-96C2-6700FBD5409F Q33719973-D58632A7-66CB-4C19-B36E-C3C6F3AEDDAD Q33937882-23210C58-5AC6-401A-9512-3F46AE891488 Q33945955-A84B0A44-B08F-4FEC-9257-F7E48A02731B Q33949907-45D66DAA-9FC2-4035-89E6-8C534709B2B7 Q34009845-3582A224-733C-4419-A509-0126304B4228 Q34037876-317E09B5-95AD-4E45-AFF8-6FB6C4A214DC Q34049184-DFB85345-9FEC-4A6B-B060-2F95F4A631FC Q34110567-60348D87-1C98-4AEF-9ABB-8D132FAD87FE Q34124208-B465B663-1D67-4943-8678-A81411B0C258 Q34255948-65F863E6-EE84-4135-8DA9-8A422EF9D9E3 Q34276070-A8131098-5AD8-496F-A2E6-ABD7B1806487 Q34299043-B4408B61-79F8-4506-8A4A-98168E77E39A Q34308955-586F9BC0-682C-4BDD-BE63-ED6A011B200A Q34347517-4C99937B-252C-4A59-B017-9F2A15D054A2 Q34462350-2D3604A7-CB6D-4699-99C6-2F5BAA35D495 Q34467807-DA2AC8E1-B332-43D6-A1A1-E24D75720103 Q34475795-F99DEB5A-D86D-4D5D-8194-F9E53C3DB843 Q34502078-4D2F53D9-D856-46AA-95E4-902A74979681 Q34578119-090C934C-FEE4-479D-8FDE-4C8EEBCC8579 Q34614608-71E115E7-289D-415D-8FD5-CBFC04193318 Q34660278-BA60406B-CC58-4D67-838A-620F5CDE5E1D Q34900010-528C3AC4-3612-43A2-87BF-B298691A6719 Q35018525-F6BE5A05-16A7-4662-A463-28254326CA3C Q35053031-99686C8D-6671-4B3C-B105-07030807F196 Q35066912-7693CC39-EFEF-4CCD-9231-975933067523 Q35104929-EB4E88AC-5C9A-4F7E-A54B-8FD11B3D10ED Q35123700-E6983A38-27F1-4879-B59C-83168DB19B1F Q35144943-9AAD852A-4642-477D-94F6-EDBD91A06F6A Q35161069-FDFEFD8B-2233-41BA-A8B3-407F8EA5A4FC Q35187373-13BFD0AF-09C5-4FC4-8075-D93B6FAC3D34 Q35244082-EA10CF7C-D6AD-49D8-8135-DF9B533BFBE5 Q35374035-60BB3805-31B3-4678-92BC-810EDAE919E1

P2860

Serum autoantibodies as biomarkers for early cancer detection.

http://www.wikidata.org/entity/Q37622471

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum autoantibodies as biomarkers for early cancer detection.

@en

Serum autoantibodies as biomarkers for early cancer detection.

@nl

type

label

Serum autoantibodies as biomarkers for early cancer detection.

@en

Serum autoantibodies as biomarkers for early cancer detection.

@nl

prefLabel

Serum autoantibodies as biomarkers for early cancer detection.

@en

Serum autoantibodies as biomarkers for early cancer detection.

@nl

P1433

Q37622471-BBEDB6DD-8246-46FA-AB7B-F821208C3BEB

P1476

Q37622471-E61FD681-3D00-4AEF-B763-5545A8F329AB

P2093

Q37622471-0A390FC3-23F1-499F-8532-28431E6E3ADB

Q37622471-B67B221A-A085-4744-B31F-911706E0B5ED

Q37622471-DD7B1CD1-E3F9-4E14-B744-3FEAB3ADCB56

Q37622471-EC0D93E5-F387-4724-81E6-02FA9DA28A63

P2860

Q37622471-0007654A-F74D-41A4-BDDB-E1B859AF1F4A

Q37622471-00B6EA29-F15F-42AB-BA72-A14E0BB423E0

Q37622471-01F0A232-A8F0-4D42-998A-BA0E288FCE65

Q37622471-0243592C-47DC-49C4-8594-E36B0329B607

Q37622471-0351A509-AAA1-428D-A0AC-6CDA37E067AD

Q37622471-04FCB7BD-05BC-4541-8EB3-32EE26EB66FD

Q37622471-08237F5A-3C11-4585-910A-8AE7AD00E28F

Q37622471-098F07C4-39BA-4961-BD6A-F286C1AACFDD

Q37622471-0AB44A0F-9107-42A9-BD5F-05C28FCC0E83

Q37622471-0B11A1A4-339B-46CF-89D1-56615EDB260A

P304

Q37622471-5A2515B6-D7C9-444B-98EE-17730B278303

P31

Q37622471-BE784BC7-1074-440B-9CB2-74D00BE4E758

P356

Q37622471-A84A1C50-7A9C-4D31-A634-4DA13FD61BE6

P407

Q37622471-1A1EC131-D0DE-45BA-9111-1030A0B34A7D

P433

Q37622471-17AE5C7A-FDDD-471C-A925-A4D04AB013C9

P478

Q37622471-5A7BEEDB-70FE-4149-95D2-ACFDCA28CF66

P577

Q37622471-E9B7C763-C216-4A43-AF41-9564464CB983

P5875

Q37622471-382E24B8-2132-498A-97C2-54F926C861BB

P698

Q37622471-D1E2B1D0-593E-49C7-BA46-68DF55091519

P921

Q37622471-11B34056-3B53-40EA-A384-0D9A335C5CA7

Q37622471-65AF6C42-2446-47C4-8466-008F6A162DB0

P356

J.1742-4658.2009.07396.X

P1433

P1476

Serum autoantibodies as biomarkers for early cancer detection.

@en

P2093

Hwee Tong Tan

http://www.w3.org/2001/XMLSchema#string

Jiayi Low

http://www.w3.org/2001/XMLSchema#string

Maxey C M Chung

http://www.w3.org/2001/XMLSchema#string

Seng Gee Lim

http://www.w3.org/2001/XMLSchema#string

P2860

Self-assembling protein microarrays

Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma

Human neoplasms elicit multiple specific immune responses in the autologous host

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer

A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer

Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage

Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma.

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

P304

6880-6904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-4658.2009.07396.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

276

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38040062

http://www.w3.org/2001/XMLSchema#string

P698

19860826

http://www.w3.org/2001/XMLSchema#string

P921